Atomoxetine Hydrochloride
Generic Details
Generic Name
Atomoxetine Hydrochloride
Other Names
- Strattera
Drug Class
- Selective Norepinephrine Reuptake Inhibitor
Chemical Formula
C17H21NO·HCl
Molecular Weight
291.82 g/mol
Mechanism of Action
- Inhibits the reuptake of norepinephrine
Indications
- Attention deficit hyperactivity disorder (ADHD)
Common Dosage Forms
- Capsule
Typical Dosage
- Initially 40 mg once daily, may increase up to 100 mg/day
Pediatric Dosage
- Age 6-12 years: Start with 0.5 mg/kg daily, may increase up to 1.2 mg/kg/day
Geriatric Dosage
- Not established
Side Effects
- Nausea
- Insomnia
- Decreased appetite
- Dry mouth
Contraindications
- Hypersensitivity to atomoxetine
- Narrow-angle glaucoma
Pregnancy Category
- C - Risk cannot be ruled out
Lactation Safety
- Use caution or avoid
Drug Interactions
- Monoamine oxidase inhibitors (MAOIs)
- Selective serotonin reuptake inhibitors (SSRIs)
Overdose Symptoms
- Agitation
- tachycardia
- hypertension
- seizures
Antidote for Overdose
- No specific antidote, supportive care
Storage Conditions
- Store at room temperature in a tightly closed container
Pharmacokinetics
- Absorption: Rapidly absorbed after oral administration
- Distribution: Widely distributed in the body
- Metabolism: Primarily metabolized by the CYP2D6 enzyme
- Excretion: Mainly excreted in the urine
Precautions
- History of suicidal ideation
- Cardiovascular disease
Warnings
- Black box warning for increased risk of suicidal ideation in children and adolescents
Others
- Atomoxetine may take several weeks to show full effect in the treatment of ADHD.